Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Parkinsonism & Related Disorders
|
September 6, 2024
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and <sup>123</sup>I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses
Ryosuke Shimasaki, Masanori Kurihara, Keiko Hatano, et al.
Rinsho Shinkeigaku = Clinical Neurology
|
April 12, 2026
[Early-onset Alzheimer's disease with PSEN1 G206D mutation presenting with amnesia at an onset age of 29 years old]
Kai Funakawa, Masanori Kurihara, Kensuke Takahashi, et al.
Journal of Alzheimer'S Disease Reports
|
March 4, 2025
Sentiment analysis of social media responses to the approval of lecanemab for the treatment of Alzheimer's disease in Japan
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
BMJ Neurology Open
|
September 1, 2022
Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
Kensaku Kasuga, Masataka Kikuchi, Tamao Tsukie, et al.
Annals of Neurology
|
September 25, 2018
Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease
Ryoko Ihara, Benjamin D Vincent, Michael R Baxter, et al.
NPJ Parkinson'S Disease
|
October 21, 2024
α-synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease
Masanori Kurihara, Katsuya Satoh, Ryosuke Shimasaki, et al.
Human Molecular Genetics
|
June 28, 2013
RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy
Ryoko Ihara, Koji Matsukawa, Yusei Nagata, et al.
Alzheimer'S Research & Therapy
|
October 2, 2024
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 22, 2019
Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
Atsushi Iwata, Takeshi Iwatsubo, Ryoko Ihara, et al.
Aging
|
August 7, 2025
Age-related trends in amyloid positivity in Parkinson's disease without dementia
Keiko Hatano, Masashi Kameyama, Masanori Kurihara, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Parkinsonism & Related Disorders
|
September 6, 2024
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and <sup>123</sup>I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses
Ryosuke Shimasaki, Masanori Kurihara, Keiko Hatano, et al.
Rinsho Shinkeigaku = Clinical Neurology
|
April 12, 2026
[Early-onset Alzheimer's disease with PSEN1 G206D mutation presenting with amnesia at an onset age of 29 years old]
Kai Funakawa, Masanori Kurihara, Kensuke Takahashi, et al.
Journal of Alzheimer'S Disease Reports
|
March 4, 2025
Sentiment analysis of social media responses to the approval of lecanemab for the treatment of Alzheimer's disease in Japan
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
BMJ Neurology Open
|
September 1, 2022
Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
Kensaku Kasuga, Masataka Kikuchi, Tamao Tsukie, et al.
Annals of Neurology
|
September 25, 2018
Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease
Ryoko Ihara, Benjamin D Vincent, Michael R Baxter, et al.
NPJ Parkinson'S Disease
|
October 21, 2024
α-synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease
Masanori Kurihara, Katsuya Satoh, Ryosuke Shimasaki, et al.
Human Molecular Genetics
|
June 28, 2013
RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy
Ryoko Ihara, Koji Matsukawa, Yusei Nagata, et al.
Alzheimer'S Research & Therapy
|
October 2, 2024
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 22, 2019
Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
Atsushi Iwata, Takeshi Iwatsubo, Ryoko Ihara, et al.
Aging
|
August 7, 2025
Age-related trends in amyloid positivity in Parkinson's disease without dementia
Keiko Hatano, Masashi Kameyama, Masanori Kurihara, et al.
Page
of 6